BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05508867-completion@plaintrial.com
DTSTAMP:20261028T044710Z
DTSTART;VALUE=DATE:20260108
SUMMARY:A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus
  Physician's Choice Chemotherapy in PD-(L)1-refractory\, Relapsed or Refra
 ctory Classical Hodgkin Lymphoma (MK-4280A-008) — estimated completion d
 ate
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT05508867
URL:https://plaintrial.com/trial/NCT05508867
END:VEVENT
END:VCALENDAR